Senior Client Partner, Life Sciences and Healthcare Solutions Advisory
Dr. Nadina Scott has helped Fortune 500 executive teams and business leaders achieve success by delivering value and data driven solutions in areas of Pharmaceutical Manufacturing, Specialty and Biotech Pharmacy, Pharmacy Benefits Management, population health, digital health, health equity and healthcare regulations, including the Inflation Reduction Act.
Nadina served as the Chief Product Officer and General Manager, Pharmaceutical Solutions for a major healthcare alliance of over 60 Fortune 500 employers, aligning to solve employee health and wellbeing challenges.
She also previously served as Managing Director developing and leading a top tier global pharmaceutical consulting practice, scaling revenue to over $80M.
Her experience in building large multidisciplinary, global teams to accelerate business growth makes her uniquely positioned to prioritize Korn Ferry solutions that align with business challenges faced by global companies and strategic alliances.
She is also passionate about addressing health equity and disparities and has authored papers focused on maternal health, obesity, HIV/AIDS, and Biotech pharma.
Education includes a Bachelors degree in Environmental Chemistry from the University of California, San Diego and a Doctor of Pharmacy degree from Howard University, Magna Cum Laude with Rho Chi and Phi Lambda Sigma honors. Dr. Scott completed her residency with Merck Medco/Holy Name Hospital in New Jersey and is licensed as a Registered Pharmacist. She is an active member of Women of Color in Pharma and NAHSE.
She resides in Brooklyn with her husband and two daughters. She also chairs the Governance Committee on the Board of Directors for Hamilton Madison House and sits on the Ideal Model of Care Task Force for the Arthritis Foundation.